1st Kaunas International Hematology/Oncology Colloquium
- Nadja Jäkel – Ruxolitinib for treatment of MPN and the role of HSCT
- Prof. Jerzy Holowiecki – Myeloma and the role of autologous HSCT
- Assoc. Prof. Rolandas Gerbutavicius – Autologous HSCT in multiple myeloma: First experience in Kaunas
- Prof. Kestutis Petrikonis, Dr. Domas Vaitiekus – Case Report (POEMS)
- Dr. Vladan Vucinic – New techniques in mobilization
- Prof. Marco Bregni, Busto – Autologous HSCT in solid tumors
- Dr. Ilze Trociukas – Latvian experience in autologous HSCT for multiple myeloma
- Prof. Hele Everaus – Estonian experience in autologous HSCT for multiple myeloma
- Prof. Laurent Garderet – The role of autologous HSCT in newly diagnosed and relapsed myelomas in the context of new drugs
- Prof. Norbert Schmitz – The role of transplantation in lymphoma in the context of new drugs
- Prof. Dietger Niederwieser – Future of stem cell transplantation, cellular therapy
- Prof. Gosta Gahrton – Is autologous HSCT enough for the treatment of multiple myeloma?
- Visi pranešimai – 1st Kaunas International Hematology/Oncology Colloquium